SEC Filings

Form DEF 14A
SEELOS THERAPEUTICS, INC. filed this Form DEF 14A on 04/12/2019
Document Outline
Entire Document (3073.9 KB)
Subdocument 1 - DEF 14A - DEF 14A
Page 1 - UNITED STATES
Page 2 - SEELOS THERAPEUTICS, INC.
Page 3 - Table of Contents
Page 4 - SEELOS THERAPEUTICS, INC.
Page 5 - N/A
Page 6 - PROPOSAL NO. 1
Page 7 - Class I Director Nominated for Election
Page 8 - Class II Directors Continuing in Office until 2021
Page 9 - THE BOARD OF DIRECTORS RECOMMENDS A VOTE FOR THE NOMINEE IDENTIFIED ABOVE.
Page 10 - PROPOSAL NO. 2
Page 11 - Pre-Approval Policies and Procedures
Page 12 - PROPOSAL NO. 3
Page 13 - PROPOSAL NO. 4
Page 14 - BOARD OF DIRECTORS AND COMMITTEES AND CORPORATE GOVERNANCE
Page 15 - Director Nominations and Stockholder Communications
Page 16 - Compensation Committee Interlocks and Insider Participation
Page 17 - EXECUTIVE OFFICERS
Page 18 - Narrative Disclosure to Summary Compensation Table
Page 19 - 2018 Awards Granted Time-Based Stock Options
Page 20 - Outstanding Equity Awards as of December 31, 2018
Page 21 - Payments Upon Termination or Change In Control
Page 22 - N/A
Page 23 - Brian T. Dorsey
Page 24 - N/A
Page 25 - Neil Morton
Page 26 - N/A
Page 27 - DIRECTOR COMPENSATION
Page 28 - Non-Employee Director Compensation for 2018
Page 29 - REPORT OF THE AUDIT COMMITTEE
Page 30 - CERTAIN RELATIONSHIPS AND RELATED PARTY TRANSACTIONS
Page 31 - SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED STOCKHOLDER MATTERS
Page 32 - SECTION 16(A) BENEFICIAL OWNERSHIP REPORTING COMPLIANCE
Page 33 - WHERE YOU CAN FIND ADDITIONAL INFORMATION
Page 34 - N/A
Page 35 - N/A